MERSANA THERAPEUTICS
0.3800
14-5月-25 16:45:00
15 分の遅延
株式
+0.0218
+6.09%
本日の幅
0.3472 - 0.3820
ISIN
N/A
ソース
NASDAQ
-
28 2 2024 07:00:08 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics to Present at Upcoming Investor Conferences
27 2 2024 08:01:15 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics to Host Fourth Quarter and Year End 2023 Conference Call on February 28, 2024
21 2 2024 08:00:22 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics to Participate in Guggenheim’s 6th Annual Biotechnology Conference
01 2 2024 08:00:46 提供 Nasdaq GlobeNewswire
-
05 1 2024 08:01:19 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 12 2023 16:30:01 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Provides Business Update and Announces Third Quarter 2023 Financial Results
07 11 2023 07:00:55 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics to Host Third Quarter 2023 Conference Call on November 7, 2023
31 10 2023 16:30:25 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces FDA has Lifted Clinical Hold on Phase 1 Clinical Trial of XMT-2056
31 10 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Changes in Leadership
06 9 2023 07:00:40 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Second Quarter 2023 Financial Results
08 8 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 8 2023 16:05:52 提供 Nasdaq GlobeNewswire
-
27 7 2023 07:06:23 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 7 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Partial Clinical Hold on UP-NEXT and UPGRADE-A Clinical Trials
15 6 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 6 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics to Present at Upcoming Investor Conferences
24 5 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Provides Business Update and Announces First Quarter 2023 Financial Results
09 5 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 5 2023 16:05:01 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics to Present at Bank of America Securities 2023 Healthcare Conference
03 5 2023 08:00:01 提供 Nasdaq GlobeNewswire